FDA Enforcement In Brief
This article was originally published in The Tan Sheet
Executive Summary
MRSA claims attract hand sanitizer sweep
You may also be interested in...
Hand Sanitizers Limited To Sterile Claims But Cleaning Up Amid Flu Worries
Consumer fears stemming from a second wave of 2009-H1N1 flu virus cases are helping drive sales of hand sanitizers, but marketers must tread lightly when it comes to associating their products with protection against viruses
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.